Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Journal of General Virology

• Publication date

  1985-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1099/0022-1317-66-5-1159PMID 2582084
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies.

  1984cited by this paper
• Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b.

  1984cited by this paper
• The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1.

  1983cited by this paper
• A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1.

  1983cited by this paper
• Synthetic peptide immunogens as vaccines.

  1983cited by this paper
• Location and primary structure of a major antigenic site for poliovirus neutralization

  1983cited by this paper
• Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies

  1983cited by this paper
• Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3

  1983cited by this paper
• Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3.

  1982cited by this paper
• Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping.

  1982cited by this paper
• Cloned poliovirus complementary DNA is infectious in mammalian cells.

  1981cited by this paper

• Structural insight into the assembly and D antigenicity of polio type 1 stabilized virus-like particles.

  2026cites this paper
• The Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens.

  2023cites this paper
• Identification of four neutralizing antigenic sites on the enterovirus D68 capsid

  2023cites this paper
• A human monoclonal antibody binds within the poliovirus receptor-binding site to neutralize all three serotypes

  2023cites this paper
• Genetic characterization and molecular evolution of type 3 vaccine-derived polioviruses from an immunodeficient patient in China

  2023cites this paper
• Mapping of the epitopes of poliovirus type 2 in complex with antibodies.

  2015cites this paper
• Characterization of Poliovirus Neutralization Escape Mutants of Single-Domain Antibody Fragments (VHHs)

  2015cites this paper
• Structural studies of virus-antibody immune complexes (poliovirus type I): Characterization of the epitopes in 3D.

  2015cites this paper
• Limited and Localized Outbreak of Newly Emergent Type 2 Vaccine-Derived Poliovirus in Sichuan, China

  2014cites this paper
• Antigenic modification of polioviruses by host proteolytic enzymes

  2005cites this paper
• Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months.

  2004cites this paper
• Antigenic sites of coxsackie A9 virus inducing neutralizing monoclonal antibodies protective in mice.

  2003cites this paper
• Antibody Responses to Antigenic Sites 1 and 3 of Serotype 3 Poliovirus after Vaccination with Oral Live Attenuated or Inactivated Poliovirus Vaccine and after Natural Exposure

  2000influential citation
• Genetic Basis for Immunological Aberrations in Poliovirus Sabin Serotype 3 Strains Imported in The Netherlands

  1999cites this paper
• Immunity to poliovirus after infection and vaccination

  1999cites this paper
• Reverse genetics of picornaviruses.

  1999cites this paper
• Identification of neutralizing epitopes on a European strain of swine vesicular disease virus.

  1999cites this paper
• Antigenic sites of coxsackievirus A9.

  1998cites this paper
• Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variants.

  1997cites this paper
• Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies

  1997cites this paper
• Poliovirus and Other Enteroviruses

  1997cites this paper
• Lymphocyte recognition of picornaviruses.

  1995cites this paper
• Review article Lymphocyte recognition of picornaviruses

  1995cites this paper
• Characterization of the N-terminal part of the neutralizing antigenic site I of coxsackievirus B4 by mutation analysis of antigen chimeras.

  1994cites this paper
• Strategies for mapping and imitating viral B-cell epitopes

  1994cites this paper
• Use of conserved rhinovirus peptide antisera for mapping B-cell epitopes and detection of a broad range of picornaviruses /

  1994cites this paper
• Current and Future Approaches to Vaccination Against Virus Diseases

  1994cites this paper
• Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus

  1993influential citation
• Molecular basis of antigenic structures of poliovirus: implications for their evolution during morphogenesis

  1992cites this paper
• Antigenic structure of chimeras of type 1 and type 3 polioviruses involving antigenic sites 2, 3 and 4.

  1991cites this paper
• Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B.

  1991cites this paper
• Characterization of Mengo virus neutralization epitopes.

  1991cites this paper
• Production of Poliovirus Vaccines: Past, Present, and Future

  1990cites this paper
• A new antigenic site of poliovirus recognized by an intertypic cross-neutralizing monoclonal antibody.

  1990cites this paper
• Antigenic structure of picornaviruses.

  1990cites this paper
• Poliovirus vaccines. A continuing challenge.

  1990cites this paper
• Differences in conformation of type 3 poliovirus antigenic sites on non-infectious empty particles and infectious virus.

  1990cites this paper
• Antigenic structure of chimeras of type 1 and type 3 poliovirus involving antigenic site 1.

  1990cites this paper
• Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1

  1990cites this paper
• The complete nucleotide sequence of a pathogenic swine vesicular disease virus.

  1990cites this paper
• Type 3 poliovirus/Finland/1984 is genetically related to common Mediterranean strains.

  1990cites this paper
• The antigenic structure of poliovirus.

  1989cites this paper
• Poliovirus: three-dimensional structure of a viral antigen.

  1989cites this paper
• Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus.

  1989cites this paper
• The outbreak of poliomyelitis in Finland in 1984-1985: significance of antigenic variation of type 3 polioviruses and site specificity of antibody responses in antipolio immunizations.

  1989cites this paper
• N-AgIB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152.

  1989cites this paper
• Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus

  1989cites this paper
• Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.

  1989cites this paper
• Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector.

  1989cites this paper
• Formalin inactivation of the lactate dehydrogenase-elevating virus reveals a major neutralizing epitope not recognized during natural infection

  1988cites this paper
• Antigenic variation among 173 strains of type 3 poliovirus isolated in Finland during the 1984 to 1985 outbreak.

  1988cites this paper
• Evidence for a complex structure of neutralization antigenic site I of poliovirus type 1 Mahoney

  1988cites this paper
• Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants.

  1988cites this paper
• Vaccination against poliomyelitis: present possibilities and future prospects.

  1988cites this paper
• Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys.

  1988cites this paper
• Three-dimensional model of the capsid proteins of two biologically different Theiler virus strains: clustering of amino acid difference identifies possible locations of immunogenic sites on the virion.

  1988cites this paper
• Chemical Synthesis of Poliovirus Peptides and Neutralizing Antibody Responses

  1988cites this paper
• Three-dimensional structure of poliovirus serotype 1 neutralizing determinants

  1988cites this paper
• Antigen chimaeras of poliovirus as potential new vaccines

  1988cites this paper
• Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants.

  1987cites this paper
• Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus

  1987influential citation
• Toward new viral vaccines for man.

  1987cites this paper
• Binding site of neutralizing monoclonal antibodies obtained after in vivo priming with purified VP1 of poliovirus type 1 is located between amino acid residues 93 and 104 of VP1.

  1987cites this paper
• The Structure of Poliovirus at 2.9 Å Resolution: Crystallographic Methods and Biological Implications

  1987cites this paper
• Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus.

  1987cites this paper
• Poliomyelitis in North America: the disease is not dead yet.

  1987cites this paper
• Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14

  1986cites this paper
• Studies on the molecular aspects of antigenic structure and virulence of poliovirus

  1986cites this paper
• Prospects for synthetic peptide vaccines against poliovirus

  1986cites this paper
• Construction of poliovirus intertypic recombinants by use of cDNA

  1986cites this paper
• Reactivity of anti-peptide and anti-poliovirus type 3 monoclonal antibodies with synthetic peptides.

  1986cites this paper
• The Three-dimensional Structure of Poliovirus: Implications for Virus Evolution, Assembly, and Immune Recognition

  1986cites this paper
• Antigenic structure of polioviruses of serotypes 1, 2 and 3.

  1986cites this paper
• Antigenic and molecular properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated population.

  1986cites this paper
• Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee.

  1986cites this paper
• Modulation of humoral response to a 12-amino-acid site on the poliovirus virion

  1986cites this paper
• Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population.

  1986cites this paper
• The genetic basis for the attenuation of the sabin type 3 poliomyelitis vaccine, P3/Leon/12a1b.

  1986influential citation
• Induction by synthetic peptides of broadly reactive, type-specific neutralizing antibody to poliovirus type 3.

  1985cites this paper